ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

ACRV Acrivon Therapeutics Inc

9.59
1.13 (13.36%)
04 May 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)
Total Assets 87.71M181.23M170.2M160.05M151.09M
Total Current Assets 78.67M132.1M123.96M153.28M144.49M
Cash and Equivalents 32.08M29.52M27.49M38.07M29.86M
Total Non-Current Assets 11.19M51.22M48.23M8.74M8.6M
Total Liabilities 10.81M10.75M9.73M10.87M12.94M
Total Current Liabilities 6.39M6.52M5.68M7.02M9.3M
Total Non-Current Liabilities 4.42M4.24M4.05M3.85M3.64M
Common Equity 2k22k22k22k22k
Retained Earnings -47.1M-56.03M-68.79M-82.7M-97.17M
Year End 31 December 2023 202120222023
USD (US$)USD (US$)USD (US$)
Total Assets 106.59M181.23M138.27M
Total Current Assets 100.41M132.1M129.69M
Cash and Equivalents 99.6M29.52M36.02M
Total Non-Current Assets -23.81M170.48M121.2M
Total Liabilities 7.88M10.75M17.07M
Total Current Liabilities 2.91M6.52M13.3M
Total Non-Current Liabilities 4.96M4.24M3.77M
Total Equity -23.81M170.48M121.2M
Common Equity 4k22k23k
Retained Earnings -24.87M-56.03M-116.42M

Your Recent History

Delayed Upgrade Clock